Clinical trial
Regenerative Therapy for Vertical Defects Comparing Demineralized Freeze Dried Bone Allograft (DFDBA) and Regenafil
NCT00255970 is registered in ClinicalTrials.gov with RTI Surgical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Regenerative Therapy for Vertical Defects Comparing Demineralized Freeze Dried Bone Allograft (DFDBA) and Regenafil
- Lead sponsor
- RTI Surgical
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- November 30, 2007
- Enrollment
- 40 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.